Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Millennium issued U.S. patent for human melanoma gene

Oct. 16, 1997

New immunosuppressive, anticancer compounds from Kyowa Hakko

Oct. 15, 1997

Resistance modulators prepared by Byk Gulden

Oct. 15, 1997

Mayo Clinic to collaborate in developing Dendreon's dendritic cell therapy

Oct. 15, 1997

ONYX-015 combination enters phase II; U.S. patent awarded

Oct. 15, 1997

St. Jude researchers discover new role for p53

Oct. 14, 1997

Pharmacia & Upjohn discloses new distamycin derivatives

Oct. 14, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

Improved efficacy of MEN-10755 related to apoptosis?

Oct. 13, 1997

DUROS leuprolide enters phase III for prostate cancer

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...